West Pharmaceutical Services, Inc. (NYSE: WST - Get Free Report) has earned an average rating of "Mo

Caisse de depot et placement du Quebec purchased a new stake in West Pharmaceutical Services, Inc. (

EXTON, Pa., Aug. 26, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global l

Barbara Oil Co. acquired a new stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) dur

Advisors Capital Management LLC bought a new stake in West Pharmaceutical Services, Inc. (NYSE: WST)

West Pharmaceutical Services has surged 38.1% since March-end as HVP demand, GLP-1 growth and produc

West Pharmaceutical (WST) might move higher on growing optimism about its earnings prospects, which

WST's faster HVP growth, wider margins and stronger earnings outlook support the bull case, but its

West Pharmaceutical's Q2 beat, faster HVP growth and wider margins drove a higher 2026 outlook, stre

WST's HVP growth, wider margins and raised 2026 outlook support its recent rally, but a premium valu

Citigroup analyst Joanne Wuensch maintains West Pharmaceutical Servs (NYSE:WST) with a Buy and ra

West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by c

Dimensional Fund Advisors LP lifted its stake in shares of West Pharmaceutical Services, Inc. (NYSE:

Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a

Bank of Nova Scotia increased its holdings in shares of West Pharmaceutical Services, Inc. (NYSE: WS

West Pharmaceutical Services delivered a strong 2Q26, beating on both revenue ($872.3M, +13.8% YoY)

West Pharmaceutical Services NYSE: WST raised its full-year 2026 outlook after reporting second-quar

WST tops Q2 earnings and revenue estimates, lifts its 2026 EPS outlook and sees shares surge as high

West Pharmaceutical Services, Inc. (WST) Q2 2026 Earnings Call Transcript

West Pharmaceutical Services, Inc. (NYSE:WST) reported better than expected second quarter 2026 earn

West Pharmaceutical reported Q2 earnings and revenue beat, higher 2026 guidance, and continued stren

While the top- and bottom-line numbers for West Pharmaceutical (WST) give a sense of how the busines

West Pharmaceutical Servs (NYSE:WST) reported second-quarter financial results on Thursday. The tran

West Pharmaceutical Services (WST) came out with quarterly earnings of $2.37 per share, beating the

Companies Reporting Before The Bell • Altisource Portfolio (NASDAQ:ASPS) is estimated to report quar

West Pharmaceutical Servs (NYSE:WST) raises FY2026 Adj EPS guidance from $8.40-$8.75 to $8.85-$9.05

West Pharmaceutical Servs (NYSE:WST) raises FY2026 GAAP EPS guidance from $8.15-$8.50 to $8.85-$9.05

West Pharmaceutical Servs (NYSE:WST) is looking for Q3 Adj EPS of $2.14-$2.24 vs $2.12 analyst estim

West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.37 per share which beat the a

https://www.sec.gov/ix?doc=/Archives/edgar/data/0000105770/000010577026000093/wst-20260714.htmThe te

BNP Paribas analyst Curtis Moiles initiates coverage on West Pharmaceutical Servs (NYSE:WST) with

Morgan Stanley analyst Kallum Titchmarsh maintains West Pharmaceutical Servs (NYSE:WST) with a Eq

Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs (NYSE:WST) with a

Keybanc analyst Paul Knight maintains West Pharmaceutical Servs (NYSE:WST) with a Overweight and

Wall Street analysts upgraded AJG & BRC. See analyst rating changes & how they view BRC stoc

Barclays analyst Luke Sergott upgrades West Pharmaceutical Servs (NYSE:WST) from Equal-Weight to

Stephens & Co. analyst Steven Etoch reiterates West Pharmaceutical Servs (NYSE:WST) with a Ov

Morgan Stanley analyst Kallum Titchmarsh maintains West Pharmaceutical Servs (NYSE:WST) with a Eq

Donald Trump disclosed up to $680,000 in Eli Lilly stock purchases as Medicare initiatives advanced

West Pharmaceutical disclosed a cyberattack that disrupted operations as analysts assess financial r

Barclays analyst Luke Sergott maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight

West Pharmaceutical beats Q1 estimates on strong GLP-1 demand, raises 2026 outlook, and authorizes $

U.S. stocks dipped as Iran-Hormuz tensions lifted oil, IBM and ServiceNow cratered, and defensive se

U.S. stocks were lower on Thursday, with the Dow Jones dropping over 200 points. Comcast's stron

WST: 16% | West Pharmaceutical Services shares are trading higher after the company reported better-

West Pharmaceutical Servs (NYSE:WST) is looking for Q2 Adj EPS of $2.05-$2.12 vs $2.00 analyst estim

West Pharmaceutical Servs (NYSE:WST) sees Q2 sales of $830.000 million-$850.000 million vs $818.537